Press Releases about Lexaria Bioscience Corp WT![]() ![]() ![]() ![]() ![]() Via AccessWire
Topics
Intellectual Property
![]() ![]() Via AccessWire
![]() Via AccessWire
![]()
Lexaria Grants License to AnodGen Bioceuticals
June 08, 2022
Via AccessWire
![]() Via AccessWire
Exposures
Product Safety
![]() Via AccessWire
![]() ![]()
Lexaria Announces 2022 Annual Meeting Results
June 01, 2022
Via AccessWire
![]() ![]() Via AccessWire
![]() ![]()
Lexaria Provides Update on Human Nicotine Study NIC-H22-1
April 12, 2022
Via AccessWire
![]() Via AccessWire
![]()
Lexaria Begins DehydraTECH-CBD Epilepsy Research Program
March 15, 2022
Via AccessWire
![]()
Lexaria Granted Important New Oral Nicotine Patent
March 08, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() Via AccessWire
![]()
Lexaria Provides Annual Letter From the CEO
January 27, 2022
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.